One of the challenges that restricts the evolving extracellular vesicle (EV) research field is
the lack of a consensus method for EV separation. This may also explain the diversity of the …

The clinical presentation of renal cell cancer (RCC) is shifting towards incidental and early
detection, creating new challenges in RCC diagnosis. Overtreatment might be reduced with …

CD9 is a crucial regulator of cell adhesion in the immune system and plays important
physiological roles in hematopoiesis, blood coagulation or viral and bacterial infections. It is …

Extracellular vesicles (EVs) have considerable potential as diagnostic, prognostic, and
therapeutic agents, in large part because molecular patterns on the EV surface betray the …

Serum prostate-specific antigen (sPSA) testing has helped to increase early detection of and
decrease mortality from prostate cancer. However, since sPSA lacks specificity, an invasive …

Prostate cancer (PCa) has become a public health concern in elderly men due to an ever‐
increasing number of estimated cases. Unfortunately, the available treatments are …

Renal cell carcinoma is a lethal disease that is often discovered incidentally. New non-
invasive biomarkers are needed to aid diagnosis and treatment. Extracellular vesicles (EVs) …

Liquid biopsy has emerged as a complement to invasive tissue biopsy to guide cancer
diagnosis and treatment. The common liquid biopsy biomarkers are circulating tumor cells …

Extracellular vesicles (EVs) are nano-sized lipid bilayer encapsulated particles with a
molecular cargo that appears to play important roles within the human body, such as in cell …

Objective To propose EV-derived mRNA as a potential diagnostic biomarker detecting the
presence of clear cell renal cell carcinoma (ccRCC). There is currently no kidney cancer …